Skip to main content
Livermore
Livermore
ZHEN

Satellos Bioscience Inc.

MSLE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001421642

No open-market purchases or sales by Satellos Bioscience Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $59.6M in total; no superinvestor holds it.

Holders of 5% or more of MSLE

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Satellos Bioscience Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of MSLE
HolderLatest formStakeChangeFirst filedLatest filingFiling
Qiming U.S. Healthcare Fund III, L.P.13G8.30%1.73M sharesNewMay 12, 20261 filingMay 12, 2026SEC
Bloom Brian Matthew13G7.35%1.13M sharesNewMay 15, 20261 filingMay 15, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

2 Schedule 13D and 13G filings on Satellos Bioscience Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on MSLE
Filed (ET)FilerFormStakeChangeEvent dateFiling
May 15, 20263:04 PM ETBloom Brian Matthewand 2 others13G7.35%1.13M sharesNewFeb 6, 2026SEC
May 12, 20264:23 PM ETQiming U.S. Healthcare Fund III, L.P.and 3 others13G8.30%1.73M sharesNewMar 31, 2026SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Satellos Bioscience Inc. shares.

No Form 144 notices for Satellos Bioscience Inc. are on file.